Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
Consumer China Asia Pacific

Industry Roundup: No GRAS For PHOs, Pfizer Expands In China, MusclePharm Targets Over-40 Consumers

This article was originally published in The Tan Sheet

  • News

Executive Summary

Partially hydrogenated oils lose GRAS; Pfizer expands consumer product output in China; MusclePharm adding direct sales; U.K. requires registration, logo for online sales; and more news in brief.

You may also be interested in...



Industry Roundup: Vitamin Shoppe, Walgreen/Rite Aid, BioPharmX

FTC requests more from Walgreen, Rite Aid; SDC manufactures for Axxess; Human Roots expands online sales; and more news in brief.

Industry Roundup: Vitamin Shoppe, Walgreen/Rite Aid, BioPharmX

FTC requests more from Walgreen, Rite Aid; SDC manufactures for Axxess; Human Roots expands online sales; and more news in brief.

Executive Decisions Roundup

POM Wonderful pomegranate dietary supplement marketer The Wonderful Co. is represented in the Aspen Institute’s inaugural “Health Innovators” program; nutritional and sports supplement brands EXOS and MusclePharm and eye care brand EyePromise sign pro athletes; and more news in brief.

Table

View full table

Related Content

HBW Insight Pink Sheet

Topics

Related Companies

Tags:
Consumer China Asia Pacific
UsernamePublicRestriction

Register

PS107737

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By